ALLERGEN IMMUNOTHERAPY

1981, Position statements: Controversial techniques, J Allergy Clin Immunol, 67, 333, 10.1016/0091-6749(81)90076-2 1989, Position statement: Beta-adrenergic blockers, immunotherapy and skin testing, J Allergy Clin Immunol, 84, 129, 10.1016/0091-6749(89)90186-3 1990, Position statement: Personnel and equipment to treat systemic reactions caused by immunotherapy with allergenic extracts, JACI, 85, 526 1994, Position statement: The use of epinephrine in the treatment of anaphylaxis, JACI, 94, 666 1994, Position statement: Guidelines to minimize the risk from systemic reactions caused by immunotherapy with allergenic extracts, J Allergy Clin Immunol, 93, 811, 10.1016/0091-6749(94)90265-8 Bjorkstin, 1986, Clinical and immunologic effects of oral immunotherapy with a standardized birch pollen extract, Allergy, 41, 290, 10.1111/j.1398-9995.1986.tb02031.x Bruce, 1977, The role of ragweed pollen in autumnal asthma, J Allergy Clin Immunol, 59, 450, 10.1016/0091-6749(77)90009-4 Bukantz, 1991, Adverse effects and fatalities associated with allergen immunotherapy, 51 Bush, 1991, Patient selection, 25 Creticos, 1993, The NIAID Cooperative Study of the role of immunotherapy in seasonal ragweed-induced adult asthma [abstract], J Allergy Clin Immunol, 91, 226 Creticos, 1984, Dose response of IgE and IgG antibodies during ragweed immunotherapy, J Allergy Clin Immunol, 73, 94, 10.1016/0091-6749(84)90490-1 Creticos, 1984, Evaluation by nasal pollen challenge of immunotherapy with rapidly released ragweed allergen, J Allergy Clin Immunol, 73, 141 Djurup, 1985, The IgE and IgG subclass antibody response in patients allergic to yellow jacket venom undergoing different regimens of venom immunotherapy, J Allergy Clin Immunol, 76, 46, 10.1016/0091-6749(85)90803-6 DuBuske, 1992, Special problems regarding allergen immunotherapy, Immunology Allergy Clin North Am, 12, 145, 10.1016/S0889-8561(22)00097-2 Frankland, 1954, Prophylaxis of summer hay fever and asthma: A controlled trial comparing crude grass-pollen extracts with the isolated main protein component, Lancet, 1, 1 Golden, 1981, Dose dependence of Hymenoptera venom immunotherapy, J Allergy Clin Immunol, 67, 370, 10.1016/0091-6749(81)90082-8 Grammer, 1993, Principles of immunologic management of allergic diseases due to extrinsic antigens, 264 Hedlin, 1986, Immunotherapy with cat- and dog-dander extracts. II. In vivo and in vitro effects observed in a one-year double-blind placebo study, J Allergy Clin Immunol, 77, 488, 10.1016/0091-6749(86)90184-3 Hirsch, 1982, Comparison of Rinkel injection therapy with standard immunotherapy, J Allergy Clin Immunol, 70, 183, 10.1016/0091-6749(82)90040-9 Horst, 1990, Double-blind, placebo-controlled, rush immunotherapy with a standardized Alternaria extract, J Allergy Clin Immunol, 85, 460, 10.1016/0091-6749(90)90156-X Ledford DK, Lockey RF: Immunotherapy for Allergic Disease. InBierman CW, Pearlman DS, Shapiro GG (eds): Allergy, Asthma, and Immunology from Infancy to Adulthood, 1996, p 242 Lowell, 1965, A double-blind study of the effectiveness and specificity of injection therapy in ragweed hay fever, N Engl J Med, 273, 675, 10.1056/NEJM196509232731302 Lowenstein, 1986, Immunotherapy with cat- and dog-dander extracts. III. Allergen-specific IG responses from a 1-year double-blind placebo study, J Allergy Clin Immunol, 77, 497, 10.1016/0091-6749(86)90185-5 MacDonald, 1991, In vitro synthesis of antigen-specific IgE, J Allergy Clin Immunol, 87, 245, 10.1016/0091-6749(91)91707-Z Malling, 1988, Diagnosis and immunotherapy of mould allergy. VII. IgG subclass response and relation to the clinical efficacy of immunotherapy with Cladosporium, Allergy, 43, 60, 10.1111/j.1398-9995.1988.tb02045.x Marsh, 1970, Studies on allergoids, prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component, Immunology, 18, 705 McHugh, 1990, A placebo-controlled trial of immunotherapy with two extracts of Dermatophgoides pteronyssinus in allergic rhinitis, comparing clinical outcome with changes in antigen-specific IgE, IgG and IgG subclasses, J Allergy Clin Immunol, 86, 521, 10.1016/S0091-6749(05)80208-8 Mendoza, 1982, Subthreshold and suboptimal desensitization of human basophils. I. Kinetics of decay of releasability, Int Arch Allergy Appl Immunol, 61, 101, 10.1159/000233076 Muller, 1986, Combined active and passive immunotherapy in honeybee-sting allergy, J Allergy Clin Immunol, 78, 115, 10.1016/0091-6749(86)90123-5 Nelson, 1981, The effect of preservatives and conditions of storage on the potency of allergy extract, J Allergy Clin Immunol, 67, 64, 10.1016/0091-6749(81)90047-6 Nelson, 1993, A double-blind, placebo-controlled evaluation of sublingual immunotherapy with standardized cat extract, J Allergy Clin Immunol, 92, 229, 10.1016/0091-6749(93)90166-D Noon, 1911, Prophylactic inoculation against hay fever, Lancet, 1, 1572, 10.1016/S0140-6736(00)78276-6 Norman, 1973, Diagnostic tests in ragweed hay fever: A comparison of direct skin tests, IgE antibody measurements and basophil histamine release, J Allergy Clin Immunol, 52, 210, 10.1016/0091-6749(73)90059-6 Norman, 1971, Maintenance immunotherapy in ragweed hay fever: Booster injections at six week intervals, J Allergy, 47, 273 Ohman, 1984, Immunotherapy in cat-induced asthma. Double-blind trial with evaluation of in vivo and in vitro responses, J Allergy Clin Immunol, 74, 230, 10.1016/0091-6749(84)90251-3 Oppenheimer, 1992, Treatment of peanut allergy with rush immunotherapy, J Allergy Clin Immunol, 90, 256, 10.1016/0091-6749(92)90080-L Osterballe, 1980, Immunotherapy in hay fever with two major allergens and partially purified extract of timothy grass pollen: A controlled double-blind study: In vivo variables, season, Allergy, 35, 473, 10.1111/j.1398-9995.1980.tb01795.x Pence, 1976, Immunotherapy for mountain cedar pollinosis: A double-blind controlled study, J Allergy Clin Immunol, 53, 39, 10.1016/0091-6749(76)90105-6 Randolph, 1986, Evaluation of decline in serum venom-specific IgE as a criterion for stopping venom immunotherapy, J Allergy Clin Immunol, 77, 8823, 10.1016/0091-6749(86)90379-9 Reid, 1993, Survey of fatalities from skin testing and immunotherapy 1985–1989, J Allergy Clin Immunol, 92, 6, 10.1016/0091-6749(93)90030-J Reisman, 1992, Insect sting allergy, Immunol Allergy Clin North Am, 12, 85, 10.1016/S0889-8561(22)00093-5 Reisman, 1989, Further observations of stopping venom immunotherapy: Comparison of patients stopped because of a fall in serum venom-specific IgE to insignificant levels with patients stopped prematurely by self-choice, J Allergy Clin Immunol, 83, 1049, 10.1016/0091-6749(89)90446-6 Rinkel, 1963, The management of clinical allergy. Part III. Inhalant allergy therapy, Arch Otolaryngol, 77, 205, 10.1001/archotol.1963.00750010211018 Rocklin, 1980, Generation of antigen-specific suppressor cells during allergy desensitization, N Engl J Med, 302, 1213, 10.1056/NEJM198005293022201 Sadan, 1969, Immunotherapy of pollenosis in children, N Engl J Med, 280, 623, 10.1056/NEJM196903202801201 Schatz, 1993, The course and management of asthma and allergic disease during pregnancy, 1301 Stafford, 1989, Survey of whole body extract immunotherapy for imported fire ants and other Hymenoptera-sting allergy. Report of the Fire Ant Subcommittee of the American Academy of Allergy and Immunology, J Allergy Clin Immunol, 83, 1107, 10.1016/0091-6749(89)90453-3 Steward, 1992, Systemic reactions from allergen immunotherapy [editorial], J Allergy Clin Immunol, 90, 567, 10.1016/0091-6749(92)90129-P Sundin, 1986, Immunotherapy with partially purified and standardized animal dander extract. I. Clinical results of a double-blind study on patients with animal dander asthma, J Allergy Clin Immunol, 77, 478, 10.1016/0091-6749(86)90183-1 Tamir, 1987, Generation of suppressor cells in atopic patients during immunotherapy that modulate IgE synthesis, J Allergy Clin Immunol, 79, 591, 10.1016/S0091-6749(87)80154-9 Van Metre, 1993, Immunotherapy for allergic disease, 2, 1489 Van Metre, 1982, A comparison of immunotherapy schedules for injection treatment of ragweed pollen hay fever, J Allergy Clin Immunol, 69, 181, 10.1016/0091-6749(82)90098-7 Van Metre, 1990, How should we use skin testing to quantify IgE sensitivity?, J Allergy Clin Immunol, 86, 583, 10.1016/S0091-6749(05)80216-7 Viander, 1978, The seasonal symptoms of hyposensitized and untreated hay fever patients in relation to birch pollen counts: Correlations with nasal sensitivity, prick tests and RAST, Clin Allergy, 8, 387, 10.1111/j.1365-2222.1978.tb00474.x Warner, 1978, Controlled trial of hyposensitization to Dermatophagoides pteronyssinus in children with asthma, Lancet, 2, 912, 10.1016/S0140-6736(78)91630-6 Yunginger, 1993, Insect allergy, 2, 1511